Company profile: PACT Pharma
1.1 - Company Overview
Company description
- Provider of personalized adoptive T cell therapies designed for the eradication of solid tumors.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PACT Pharma
Allarity
HQ: United States
Website
- Description: Provider of biopharmaceutical oncology therapies and predictive diagnostics for personalized cancer treatment, utilizing DRP Technology to predict patient response and refine patient selection. Pipeline includes Dovitinib for renal cell carcinoma, Stenoparib, LiPlaCis, and 2X-111.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allarity company profile →
DYSIS Medical
HQ: United Kingdom
Website
- Description: Provider of medical imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions, including the DYSIS Colposcope for imaging the cervix and lower genital tract with adjunctive acetowhitening display; DYSISmap to quantify acetowhitening and overlay a color-coded map to assist biopsy targeting; and DYSIS SMARTtrack for enhanced documentation with high-resolution images, video, and instant exam playback.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DYSIS Medical company profile →
Lymphatica Medtech
HQ: Switzerland
Website
- Description: Provider of medical device development, creating a minimally invasive solution for chronic lymphedema.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lymphatica Medtech company profile →
Spotlight Therapeutics
HQ: United States
Website
- Description: Provider of targeted biologic gene editing solutions, including Targeted Active Gene Editors (cell-targeted CRISPR-Cas ribonucleoproteins) for non-viral in vivo delivery in immuno-oncology and genetic diseases; localized eRNP editing for retinal cells via subretinal delivery; eRNP applications in the CNS; and a high-throughput screen to identify Cas fusion proteins for selective internalization and localization in primary cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spotlight Therapeutics company profile →
Incyte
HQ: United States
Website
- Description: Provider of drug discovery and development focused on building a proprietary pipeline of novel small molecule drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Incyte company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PACT Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PACT Pharma
2.2 - Growth funds investing in similar companies to PACT Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PACT Pharma
4.2 - Public trading comparable groups for PACT Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →